Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P32
Within normal range
Average
2.96%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | -100.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | -100.00% |
| Q4 2023 | 14.76% |
| Q3 2023 | -13.75% |
| Q2 2023 | 198.31% |
| Q1 2023 | -56.93% |
| Q4 2022 | -42.10% |
| Q3 2022 | -37.14% |
| Q2 2022 | -27.39% |
| Q1 2022 | -48.75% |
| Q4 2021 | 2.49% |
| Q3 2021 | 12.65% |
| Q2 2021 | -8.52% |
| Q1 2021 | 13.35% |
| Q4 2020 | 128.63% |
| Q3 2020 | -7.60% |
| Q2 2020 | 166.67% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |